Specific dermatoses of pregnancy: Advances and controversies

Expert Review of Dermatology

Volumn 5, Issue 6, 2010, Pages 633-648

  Kroumpouzos, George ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

atopic dermatitis; cholestasis; herpes gestationis; polymorphic eruption of pregnancy; prurigo of pregnancy; pruritic folliculitis of pregnancy

Indexed keywords

BENZOYL PEROXIDE; COLESTYRAMINE; CYCLOSPORIN; DEXAMETHASONE; DIPHENHYDRAMINE; ERYTHROMYCIN; IMMUNOGLOBULIN E; PIMECROLIMUS; PLACEBO; PREDNISOLONE; PREDNISONE; RIFAMPICIN; S ADENOSYLMETHIONINE; STEROID; TACROLIMUS; URSODEOXYCHOLIC ACID;

ATOPIC DERMATITIS; BENIGN CHILDHOOD EPILEPSY; BIRTH WEIGHT; BRAIN HEMORRHAGE; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FETUS DEATH; FETUS DISTRESS; FOLLICULITIS; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; INTRAHEPATIC CHOLESTASIS; INTRAUTERINE GROWTH RETARDATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PAPULAR URTICARIA; PATHOGENESIS; PATIENT CARE; PEMPHIGOID GESTATIONIS; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PRURITIC FOLLICULITIS; PRURITUS; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SIDE EFFECT; SKIN CARE; SKIN DISEASE; STILLBIRTH; ULTRAVIOLET B RADIATION;

EID: 78649498220     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/edm.10.59     Document Type: Review

References (142)

1. Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM. The specifc dermatoses of pregnancy revisited and reclassifed: results of
2. Cohen LM, Kroumpouzos G. Pruritic dermatoses of pregnancy: to lump or to split? J. Am. Acad. Dermatol. 56(4), 708-709 (2007).
3. Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating clinical fndings with hormonal and immunopathological profles. Br. J. Dermatol. 141(1), 71-81 (1999).
4. Cho S, Kim HJ, Oh SH, Park CO, Jung JY, Lee KH. The infuence of pregnancy and menstruation on the deterioration of atopic dermatitis symptoms. Ann. Dematol. 22(2), 180-185 (2010).
5. Kemmett D, Tidman MJ. The infuence of menstrual cycle and pregnancy on atopic dermatitis. Br. J. Dermatol. 125(1), 59-61 (1991).
6. Weatherhead S, Robson SC, Reynolds NJ. Eczema in pregnancy. BMJ 335 (7611), 152-154 (2007).
7. Vaughan Jones SA. Eczema in Pregnancy. In: Obstetric and Gynecologic Dermatology. Black MM, McKay M, Braude PR, Vaughan Jones SA, Margesson LJ (Eds). Mosby, London, UK, 73-78 (2002).
8. Hanifn JM, Rajka G. Diagnostic features of atopic eczema. Acta Derm. Venereol. (Stockh) 92(Suppl.), 44-47 (1980).
9. Howarth PH. ABC of allergies. Pathogenic mechanisms: a rational basis for treatment. BMJ 316(7133), 758-761 (1998).
10. Wuthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ('extrinsic') and the nonallergic ('intrinsic') AEDS. J. Investig. Allergol. Clin. Immunol. 13(1), 1-5 (2003).
11. Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 63(11), 1418-1427 (2008).
12. Moore MM, Rifas-Shiman SL, Rich-Edwards JW et al. Perinatal predictors of atopic dermatitis occurring in the frst six months of life. Pediatrics 113 (3), 468-474 (2004).
13. Ruiz RG, Kemeny DM, Price JF. Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy. Clin. Exp. Allergy 22(8), 762-766 (1992).
14. Liu CA, Wang CL, Chuang H, Ou CY, Hsu TY, Yang KD. Prenatal prediction of infant atopy by maternal but not paternal total IgE levels. J. Allergy Clin. Immunol. 112(5), 899-904 (2003).
15. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J. Am. Acad. Dermatol. 30(1), 35-39 (1994).
16. Chandra RK, Puri S, Hamed A. Infuence of maternal diet during lactation and use of formula feeds on development of atopic eczema in high risk infants. BMJ 299(6693), 228-230 (1989).
17. Bergmann RL, Diepgen TL, Kuss O, Bergmann KE et al. Breastfeeding duration is a risk factor for atopic eczema. Clin. Exp. Allergy 32(2), 205-209 (2002).
18. Chandra RK, Puri S, Suraiya C, Cheema PS. Infuence of maternal food antigen avoidance during pregnancy and lactation on incidence of atopic eczema in infants. Clin. Allergy 16 (6), 563-569 (1986).
19. Herrmann ME, Dannemann A, Grüters A et al. Prospective study of the atopy preventive effect of maternal avoidance of milk and eggs during pregnancy and lactation. Eur. J. Pediatr. 155(9), 770-774 (1996).
20. Schäfer T, Dirschedl P, Kunz B. Maternal smoking during pregnancy and lactation increases the risk for atopic eczema in the offspring. J. Am. Acad. Dermatol. 36(4), 550-556 (1997).
21. Ekström AS, Nilsson C, Holmlund U et al. IgE is expressed on, but not produced by, fetal cells in the human placenta irrespective of maternal atopy. Clin. Exp. Immunol. 127(2), 274-282 (2002).
22. Bos JD, Van Leent EJM, Sillevis Smitt JH. The millennium criteria for the diagnosis of atopic dermatitis. Exp. Dermatol. 7(4), 132-138 (1998).
23. Lin YC, Wen HJ, Lee YL, Guo YL. Are maternal psychosocial factors associated with cord immunoglobulin E in addition to family atopic history and mother immunoglobulin E? Clin. Exp. Allergy 34(4), 548-554 (2004).
24. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J. Gastroenterol. 15(17), 2049-2066 (2009).
25. Kroumpouzos G. Intrahepatic cholestasis of pregnancy: what's new. J. Eur. Acad. Dermatol. Venereol. 16(4), 316-318 (2002).
26. Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J. Am. Acad. Dermatol. 45(1), 1-19 (2001).
27. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J. Hepatol. 33(6), 1012-1021 (2000).
28. Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC. Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J. Matern. Fetal Med. 10(2), 131-135 (2001).
29. Kroumpouzos G, Cohen LM. Specifc dermatoses of pregnancy: an evidence-based systematic review. Am. J. Obstet. Gynecol. 188(4), 1083-1092 (2003).
30. Peng B, Liu S. [Study of relationship between T helper cell type-1 and type-2 cytokines and intrahepatic cholestasis of pregnancy]. Zhonghua Fu Chan Ke Za Zhi 37(9), 516-518 (2002).
31. Ling B, Yao F, Zhou Y, Chen Z, Shen G, Zhu Y Cell-mediated immunity imbalance in patients with intrahepatic cholestasis of pregnancy. Cell. Mol. Immunol. 4(1), 71-75 (2007).
32. Dixon PH, Weerasekera N, Linton KJ et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein traffcking. Hum. Mol. Genetics 9(8), 1209-1217 (2000).
33. Reyes H, Zapata R, Hernández I et al. Is a leaky gut involved in the pathogenesis of intrahepatic cholestasis of pregnancy? Hepatology 43(4), 715-722 (2006
34. Laatikainen T Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy. Am. J. Obstet. Gynecol. 132(5), 501-506 (1978).
35. Gylling H, Riikonen S, Nikkilä K, Savonius H, Miettinen TA. Oral guar gum treatment of intrahepatic cholestasis and pruritus in pregnant women: effects on serum cholestanol and other non-cholesterol sterols. Eur. J. Clin. Invest. 28(5), 359-363 (1998).
36. Hirvioja M-L, Tuimala R, Vuori J. The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br. J. Obstet Gynaecol. 99(2), 109-111 (1992).
37. Diac M, Kenyon A, Nelson-Piercy C et al. Dexamethasone in the treatment of obstetric cholestasis: a case series. J. Obstet. Gynaecol. 26(2), 110-114 (2006).
38. Glantz A, Marschall HU, Lammert F, Mattson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 42(6), 1399-1405 (2005).
39. Bloom SL, Sheffeld JS, McIntire DD, Leveno KJ. Antenatal dexamethasone and decreased birthweight. Obstet. Gynecol. 97(4), 485-490 (2001).
40. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, Doré CJ, Rutherford M. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr. Res. 50(5), 581-585 (2001).
41. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J. Hepatol. 35(1), 134-146 (2001).
42. Rodrigues CM, Fan G, Wong PY, Kren BT, Steer CJ. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med. 4(3), 165-178 (1998).
43. Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM. Correction of maternal serum bile acid profle during ursodeoxycholic acid therapy in cholestasis of pregnancy. J. Hepatol. 28(1), 91-98 (1998
44. Glantz A, Reilly SJ, Benthin L, Lammert F, Mattsson LA, Marschall HU. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 47(2), 544-551 (2008).
45. Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli M. A randomized placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br. J. Obstet. Gynaecol. 105(11), 1205-1207 (1998).
46. Floreani A, Paternoster D, Melis A, Grella PV. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur. J. Obstet. Gynecol. 67(2), 109-113 (1996).
47. Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J. Perinat. Med. 34(5), 383-391 (2006).
48. Roncaglia N, Locatelli A, Arreghini A et al. A randomized controlled trial of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of gestational cholestasis. BJOG 111(1), 17-21 (2004).
49. Marschall HU, Wagner M, Zollner G et al. Complementary stimulation of hepatobiliary transport and detoxifcation systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129(2), 476-485 (2005).
50. Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential beneft of therapy with ursodeoxycholic acid. Gut 37(4), 580-584 (1995).
51. Kondrackiene J, Beuers U, Kupcinskas L. Effcacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterolgy 129(3), 894-901 (2005).
52. Tan LK. Obstetric cholestasis: current opinions and management. Ann. Acad. Med. Singapore 32(3), 294-298 (2003).
53. Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J. Gastroenterol. 14(38), 5781-5788 (2008).
54. Kenyon AP, Piercy CN, Girling J, Williamson C, Tribe RM, Shennan AH. Obstetric cholestasis, outcome with active management: a series of 70 cases. Br. J. Obstet. Gynaecol. 109(3), 282-288 (2002).
55. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am. J. Obstet. Gynecol. 170(3), 890-895 (1994).
56. Zecca E, De Luca D, Marras M, Caruso A, Bernardini T, Romagnoli C. Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics 117(5), 1669-1672 (2006).
57. Kondrackiene J, Beuers U, Zalinkevicius R, Tauschell HD, Gintautas V, Kupcinskas L. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J. Gastroenterol. 13(46), 6226-6230 (2007).
58. Glantz A, Marschall HU, Mattson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40 (2), 467-474 (2004).
59. Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes GL, Glasinovic JC. Bile acid increases response and expression of human myometrial oxytocin receptor. Am. J. Obstet. Gynecol. 189(2), 577-582 (2003).
60. Zecca E, De Luca D, Barbato G, Marras M, Tiberi E, Romagnoli C. Predicting respiratory distress syndrome in neonates from mothers with intrahepatic cholestasis of pregnancy. Early Hum. Dev. 84(5), 337-341 (2008).
61. Oztekin D, Aydal I, Oztekin O, Okcu S, Borekci R, Tinar S. Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy. Arch. Gynecol. Obstet. 280(6), 975-979 (2009).
62. Saleh MM, Abdo KR. Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. J. Womens Health (Larchmt) 16(6), 833-841 (2007).
63. Fagan EA. Disorders of liver, biliary system and pancreas. In: Medical Disorders in Obstetric Practice. de Swiet M (Ed.). Blackwell Science, London, UK, 282-345 (2002).
64. Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A. Obstetric cholestasis: outcome with active management. Eur. J. Obstet Gynecol. Reprod. Biol. 100(2), 167-170 (2002).
65. Mays JK. The active management of intrahepatic cholestasis of pregnancy. Curr. Opin. Obstet. Gynecol. 22(2), 100-103 (2010).
66. Holmes RC, Black M. The specifc dermatoses of pregnancy. J. Am. Acad. Dermatol. 8(3), 405-412 (1983).
67. Shornick JK, Bangert JL, Freeman RG, Gilliam JN. Herpes gestationis: clinical and histologic features of twenty-eight cases. J. Am. Acad. Dermatol. 8(2), 214-224 (1983).
68. Engineer L, Bhol K, Ahmed AR. Pemphigoid gestationis: a review. Am. J. Obstet. Gynecol. 183(2), 483-491 (2000).
69. Djahansouzi S, Nestle-Kraemling C, Dall P, Bender HG, Haustein B. Herpes gestationis may present itself as a paraneoplastic syndrome of choriocarcinoma-a case report. Gynecol. Oncol. 89(2), 334-337 (2003).
70. Semkova K, Black M. Pemphigoid gestationis: Current insights into pathogenesis and treatment. Eur. J. Obst. Gynecol. Reprod. Biol. 145(2), 138-144 (2009).
71. Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin. Exp. Dermatol. 24(4), 255-259 (1999).
72. Castro LA, Lundell RB, Krause PK, Gibson LE. Clinical experience in pemphigoid gestationis: report of 10 cases. J. Am. Acad. Dermatol. 55(5), 823-828 (2006).
73. Jenkins RE, Vaughan Jones SA, Black MM. Conversion of pemphigoid gestationis to bullous pemphigoid-two refractory cases highlighting this association. Br. J. Dermatol. 135(4), 595-598 (1995).
74. Amato L, Mei S, Gallerani I, Moretti S, Fabbri P. A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid? J. Am. Acad. Dermatol. 49(2), 302-307 (2003).
75. Hern S, Harman K, Bhogal BS, Black MM. A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulins and cyclosporin. Clin. Exp. Dermatol. 23(4), 185-188 (1998).
76. Rodrigues Cdos S, Filipe P, Solana Mdel M, Soares de Almeida L, Cirne de Castro J, Gomes MM. Persistent herpes gestationis treated with high-dose intravenous immunoglobulin. Acta Derm. Venereol. 87(2), 184-186 (2007
77. Fine J, Omura EF. Herpes gestationis: persistent disease activity 11 years post partum. Arch. Dermatol. 121(7), 924-926 (1985).
78. Castle SP, Mather-Mondrey M, Bennion S, David-Bajar K, Huff C. Chronic herpes gestationis and antiphospholipid syndrome successfully treated with cyclophosphamide. J. Am. Acad. Dermatol. 34(2 Pt 2), 333-336 (1996).
79. Holmes RC, Williamson DM, Black MM. Herpes gestationis persisting for 12 years postpartum. Arch. Dermatol. 122(4), 375-376 (1986).
80. Holmes RC, Black MM, Jurecka W et al. Clues to the etiology and pathogenesis of herpes gestationis. Br. J. Dermatol. 109(2), 131-139 (1983).
81. Ibbotson SH, Lawrence CM. An ininvolved pregnancy in a patient after a previous episode of herpes gestationis. Arch. Dermatol. 131(9), 1091-1092 (1995).
82. Black MM, Najem NM. Remarkable follow-up experiences of a severe persistent case of pemphigoid gestationis. Clin. Exp. Dermatol. 30(5), 593-594 (2005).
83. Yancey KB. Herpes gestationis. Dermatol. Clin. 8(4), 727-735 (1990).
84. Patton T, Plunkett RW, Beutner EH, Deng JS, Jukic DM. IgG4 as the predominant IgG subclass in pemphigoides gestationis. J. Cutan. Pathol. 33(4), 299-302 (2006).
85. Morrison LH, Labib RS, Zone JJ, Diaz LA, Anhalt GJ. Herpes gestationis autoantibodies recognize a 180-kd human epidermal antigen. J. Clin. Invest. 81(6), 2023-2026 (1988).
86. Lin M-S, Gharia M, Fu CL et al. Molecular mapping of the major epitopes of BP180 recognized by herpes gestationis autoantibodies. Clin. Immunol. 92(3), 285-292 (1999).
87. Di Zenzo G, Calabresi V, Grosso F, Caproni M, Ruffelli M, Zambruno G. The intracellular and extracellular domains of BP180 antigen comprise novel epitopes targeted by pemphigoid gestationis autoantibodies. J. Invest. Dermatol. 127(4), 864-873 (2007).
88. Herrero-Gonzalez JE, Brauns O, Egner R et al. Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients. Eur. J. Immunol. 36(4), 1039-1048 (2006).
89. Shimanovich I, Skrobek C, Rose C et al. Pemphigoid gestationis with predominant involvement of oral mucous membranes and IgA autoantibodies targeting the C-terminus of BP180. J. Am. Acad. Dermatol. 47(5), 780-784 (2002).
90. Sitaru C, Powell J, Messer G, Bröcker EB, Wojnarowska F, Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet. Gynecol. 103, 757-763 (2004).
91. Barnadas MA, Rubiales MV, González MJ et al. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofuorescence testing in a bullous pemphigoid and pemphigoid gestationis. Int. J. Dermatol. 47(12), 1245-1249 (2008).
92. Powell AM, Sakuma-Oyama Y, Oyama N et al. Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy. Arch. Dermatol. 141(6), 705-710 (2005).
93. Lin M-S, Gharia MA, Swartz SJ, Diaz LA, Giudice GJ. Identifcation and characterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestationis. J. Immunol. 162(8), 4991-4997 (1999).
94. Fabbri P, Caproni M, Berti S et al. The role of T lymphocytes and cytokines in the pathogenesis of pemphigoid gestationis. Br. J. Dermatol. 148(6), 1141-1148 (2003).
95. Kelly SE, Black MM. Pemphigoid gestationis: placental interactions. Semin. Dermatol. 8(1), 12-17 (1989).
96. Huilaja L, Hurskainen T, Autio-Harmainen H et al. Pemphigoid gestationis autoantigen, transmembrane collagen XVII, promotes the migration of cytotrophoblastic cells of placenta and is a structural component of fetal membranes. Matrix Biol. 27(3), 190-200 (2008).
97. Al-Mutairi N, Sharma AK, Zaki A, El-Adawy E, Al-Sheltaway M, Nour-Eldin O. Maternal and neonatal pemhigoid gestationis. Clin. Exp. Dermatol. 29(2), 202-204 (2004).
98. Loo WJ, Dean D, Wojnarowska F. A severe case of recurrent pemphigoid gestationis successfully treated with minocycline and nicotinamide. Clin. Exp. Dermatol. 26(8), 726-727 (2001).
99. Amato L, Coronella G, Berti S, Gallerani I, Moretti S, Fabbri P. Successful treatment with doxycycline and nicotinamide of two cases of persistent pemphigoid gestationis. J. Dermatol. Treat. 13(3), 143-146 (2002).
100. Kreuter A, Harati I, Breuckmann F, Appelhaus C, Altmeyer P. Intravenous immune globulin in the treatment of persistent pemphigoid gestationis. J. Am. Acad. Dermatol. 51(6), 1027-1028 (2004).
101. Wohrl S, Geusau A, Karlhofer F, Derfer K, Stingl G, Zillikens D. Pemphigoid gestationis: treatment with immunoapheresis. J. Dtsch. Dermatol. Ges. 1(2), 126-130 (2003).
102. Cobo MF, Santi CG, Maruta CW, Aoki V. Pemphigoid gestationis: clinical and laboratory evaluation. Clinics (Sao Paulo) 64(11), 1043-1047 (2009).
103. Cianchini G, Masini C, Lupi F, Corona R, De Pita O, Puddu P. Severe persistent pemphigoid gestationis: long-term remission with rituximab. Br. J. Dermatol. 157(2), 388-431 (2007).
104. Vaitkevicius V, Vaitkeviciene S, Vaitkevicius P. [Case of herpes gestationis in 5th pregnancy]. Medicina (Kaunas) 38(12), 1217-1129 (2002).
105. Shornick JK, Black MM. Fetal risks in herpes gestationis. J. Am. Acad. Dermatol. 26(1), 63-68 (1992).
106. Okumus N, Önal EE, Turkuilmaz C et al. A case report of neonatal convulsions due to maternal herpes gestationis. J. Child Neurol. 22(4), 488-491 (2007).
107. Chi C-C, Wang S-H, Charles-Holmes R et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br. J. Dermatol. 160(6), 1222-1228 (2009).
108. Karna P, Broecker AH. Neonatal herpes gestationis. J. Pediatr. 119(2), 299-301 (1991).
109. Aoyama Y, Asai K, Hioki K, Funato M, Kondo N, Kitajima Y. Herpes gestationis in a mother and newborn. Arch. Dermatol. 143(9), 1168-1172 (2007).
110. Lawley TJ, Hertz KC, Wade TR, Ackerman AB, Katz SI. Pruritic urticarial papules and plaques of pregnancy. JAMA 241(16), 1696-1699 (1979).
111. Aronson IK, Bond S, Fiedler VC, Vomvouras S, Gruber D, Ruiz C. Pruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patients. J. Am. Acad. Dermatol. 39(6), 933-939 (1998).
112. Rudolph CM, Al-Fares S, Vaughan-Jones SA, Müllegger RR, Kerl H, Black MM. Polymorphic eruption of pregnancy: clinicopathology and potential risk factors in 181 patients. Br. J. Dermatol. 154(4), 54-60 (2006).
113. Normand F, Armingaud P, Estève E. Dyshidrosis and acral purpura during polymorphic eruption of pregnancy [French]. Ann. Dermatol. Venereol. 128(4), 531-533 (2001).
114. Sherley-Dale AC, Carr RA, Charles-Holmes R. Polymorphic eruption of pregnancy with bullous lesions: a previously unreported association. Br. J. Dermatol. 162(1), 208-234 (2009).
115. Goolamali SI, Salisbury JR, Higgins EM. Polymorphic eruption of pregnancy in a photodistribution: a potentially new association? Clin. Exp. Dermatol. 34(7), e381382 (2009).
116. Holmes RC, Jurecka W, Black MM. A comparative histopathologic study of polymorphic eruption of pregnancy and herpes gestationis. Clin. Exp. Dermatol. 8(5), 523-529 (1983).
117. Carli P, Tarocchi S, Mello G, Fabbri P. Skin immune system activation in pruritic urticarial papules and plaques of pregnancy. Int. J. Dermatol. 33(12), 884-885 (1994).
118. Caproni M, Giomi B, Berti S, Bianchi B, Fabbri P. Relevance of cellular infltrate and cytokines in polymorphic eruption of pregnancy (PEP). J. Dermatol. Sci. 43(1), 67-69 (2006).
119. Borrego L, Peterson EA, Diez LI et al. Polymorphic eruption of pregnancy and herpes gestationis: comparison of granulated cell proteins in tissue and serum. Clin. Exp. Dermatol. 24(3), 213-225 (1999).
120. Elling SV, McKenna P, Powell FC. Pruritic urticarial papules and plaques of pregnancy in twin and triplet pregnancies. J. Eur. Acad. Dermatol. Venereol. 14(5), 378-381 (2000).
121. Cohen LM, Capeless EL, Krusinski PA, Maloney ME. Pruritic urticarial papules and plaques of pregnancy and its relationship to maternal-fetal weight gain and twin pregnancy. Arch. Dermatol. 125(11), 1534-1536 (1989).
122. Ohel I, Levy A, Silverstein T, Holcberg G, Sheiner E. Pregnancy outcome of patients with pruritic urticarial papules and plaques of pregnancy. J. Matern. Fetal Neonatal Med. 19(5), 305-308 (2006).
123. Pauwels C, Bucaille-Fleury L, Recanati G. Pruritic urticarial papules and plaques of pregnancy: relationship to maternal weight gain and twin or triplet pregnancies. Arch. Dermatol. 130(6), 801-802 (1994).
124. Regnier S, Fermand V, Levy P, Uzan S, Aractingi S. A case-control study of polymorphic eruption of pregnancy. J. Am. Acad. Dermatol. 58(1), 63-67 (2008).
125. Im S, Lee ES, Kim W, Song J et al. Expression of progesterone receptor in human keratinocytes. J. Korean Med. Sci. 15(6), 647-654 (2000).
126. Ingber A, Alcalay J, Sandbank M. Multiple dermal fbroblasts in patients with pruritic urticarial papules and plaques of pregnancy. A clue to the etiology? Med. Hypotheses 26(1), 11-12 (1988).
127. Aractingi S, Berkane N, Bertheau P et al. Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet 352(9144), 1898-1901 (1998).
128. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl. Acad. Sci. USA 93(2), 705-708 (1996).
129. Saraswat A, Rai R, Kumar B. Lesions resembling polymorphic eruption of pregnancy several years after pregnancy. Dermatology 202(1), 82 (2001).
130. Gabbe SG. Drug therapy in autoimmune disease. Clin. Obstet. Gynecol. 26(3), 635-641 (1987).
131. Lowenstein L, Solt I, Peleg A, Brenner B, Drugan A. [Is there an association between PUPPP and preeclampsia, abruptio placentae and fetal death?] Harefuah 143(12), 861-862, 911 (2004).
132. Cicek D, Kandi B, Demir B, Turgut D. Intrahepatic cholestasis occurring with prurigo of pregnancy. Skinmed 6(6), 298-301 (2007).
133. Roger D, Vaillant L, Fignon A et al. Specifc pruritic dermatoses of pregnancy. A prospective study of 3192 women. Arch. Dermatol. 130(6), 734-739 (1994).
134. Bos JD. Reappraisal of dermatoses of pregnancy. Lancet 354(9185), 1140-1142 (1999).
135. Zoberman E, Farmer ER. Prutitic folliculitis of pregnancy. Arch. Dermatol. 117(1), 20-22 (1981).
136. Kroumpouzos G, Cohen LM. Pruritic folliculitis of pregnancy. J. Am. Acad. Dermatol. 43(1 Pt 1), 132-134 (2000).
137. Wilkinson SM, Buckler H, Wilkinson N, O'Driscoll J. Androgen levels in pruritic folliculitis of pregnancy. Clin. Exp. Dermatol. 20(3), 234-236 (1995).
138. Vaughan Jones SA, Hern S, Black MM. Neutrophil folliculitis and serum androgen levels. Clin. Exp. Dermatol. 24(5), 392-395 (1999).
139. Esteve E, Vaillant L, Bacq Y, Descamps P, Grangeponte MC, Lorette G. [Pruritic folliculitis of pregnancy: role of associated intrahepatic cholestasis?] Ann. Dermatol. Venereol. 119(1), 37-40 (1992).
140. Parlak AH, Boran C, Topçuoglu MA. Pityrosporum folliculitis during pregnancy: a possible cause of pruritic folliculitis of pregnancy. J. Am. Acad. Dermatol. 52(3 Pt 1), 528-529 (2005).
141. Kroumpouzos G. Pityrosporum folliculitis during pregnancy is not pruritic folliculitis of pregnancy. J. Am. Acad. Dermatol. 53(6), 1098-1099 (2005).
142. Reed J, George S. Pruritic folliculitis of pregnancy treated with narrowband (TL-01) ultraviolet B phototherapy. Br. J. Dermatol. 141(1), 177-179 (1999).